{"count": 4, "results": [{"_id": "7600744", "pmid": 7600744, "title": "Is ACE inhibition with lisinopril helpful in diabetic neuropathy?", "journal": "Diabet Med", "authors": ["Reja A", "Tesfaye S", "Harris ND", "Ward JD"], "date": "1995-04-01T00:00:00Z", "doi": "10.1111/j.1464-5491.1995.tb00482.x", "meta_date_publication": "1995 Apr", "meta_volume": "12", "meta_issue": "4", "meta_pages": "307-9", "score": 50090.117, "text_hl": "Is @GENE_AP2B1 @GENE_163 @@@ACE@@@ inhibition with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ helpful in @<m>DISEASE_Diabetic_Neuropathies</m> @DISEASE_MESH:D003929 @@@diabetic neuropathy@@@?", "citations": {"NLM": "Reja A, Tesfaye S, Harris ND, Ward JD. Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabet Med. 1995 Apr;12(4):307-9. PMID: 7600744", "BibTeX": "@article{7600744, title={Is ACE inhibition with lisinopril helpful in diabetic neuropathy?}, author={Reja A and Tesfaye S and Harris ND and Ward JD}, journal={Diabet Med}, volume={12}, number={4}, pages={307-9}}"}}, {"_id": "11523311", "pmid": 11523311, "title": "Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats.", "journal": "Methods Find Exp Clin Pharmacol", "authors": ["Aggarwal M", "Singh J", "Sood S", "Arora B"], "date": "2001-04-01T00:00:00Z", "doi": "10.1358/mf.2001.23.3.627945", "meta_date_publication": "2001 Apr", "meta_volume": "23", "meta_issue": "3", "meta_pages": "131-4", "score": 50084.223, "text_hl": "Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-induced @<m>DISEASE_Diabetic_Neuropathies</m> @DISEASE_MESH:D003929 @@@diabetic neuropathy@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Aggarwal M, Singh J, Sood S, Arora B. Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats. Methods Find Exp Clin Pharmacol. 2001 Apr;23(3):131-4. PMID: 11523311", "BibTeX": "@article{11523311, title={Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats.}, author={Aggarwal M and Singh J and Sood S and Arora B}, journal={Methods Find Exp Clin Pharmacol}, volume={23}, number={3}, pages={131-4}}"}}, {"_id": "8392403", "pmid": 8392403, "title": "Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.", "journal": "Acta Diabetol", "authors": ["Cameron NE", "Cotter MA", "Robertson S"], "date": "1993-01-01T00:00:00Z", "doi": "10.1007/BF00572874", "meta_date_publication": "1993", "meta_volume": "30", "meta_issue": "1", "meta_pages": "46-8", "score": 50059.668, "text_hl": "Thus, the marked functional effects seen for vasodilator treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ suggest that angiotension converting enzyme inhibitors may have potential therapeutic value in the treatment of @<m>DISEASE_Diabetic_Neuropathies</m> @DISEASE_MESH:D003929 @@@diabetic neuropathy@@@.", "citations": {"NLM": "Cameron NE, Cotter MA, Robertson S. Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril. Acta Diabetol. 1993;30(1):46-8. PMID: 8392403", "BibTeX": "@article{8392403, title={Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.}, author={Cameron NE and Cotter MA and Robertson S}, journal={Acta Diabetol}, volume={30}, number={1}, pages={46-8}}"}}, {"_id": "25680080", "pmid": 25680080, "title": "The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.", "journal": "ACS Chem Neurosci", "authors": ["Kaur P", "Muthuraman A", "Kaur M"], "date": "2015-04-15T00:00:00Z", "doi": "10.1021/cn500363g", "meta_date_publication": "2015 Apr 15", "meta_volume": "6", "meta_issue": "4", "meta_pages": "508-21", "score": 50037.957, "text_hl": "@GENE_AP2B1 @GENE_163 @@@ACE@@@ inhibitors such as @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@, @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@, @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@, @CHEMICAL_Quinapril @CHEMICAL_MESH:D000077583 @@@quinapril@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@, and @CHEMICAL_trandolapril @CHEMICAL_MESH:C052035 @@@trandolapril@@@ have been documented to ameliorate the above @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative disorders@@@. ", "citations": {"NLM": "Kaur P, Muthuraman A, Kaur M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci. 2015 Apr 15;6(4):508-21. PMID: 25680080", "BibTeX": "@article{25680080, title={The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.}, author={Kaur P and Muthuraman A and Kaur M}, journal={ACS Chem Neurosci}, volume={6}, number={4}, pages={508-21}}"}}]}